DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

DiaMedica Therapeutics Ownership Summary

DiaMedica Therapeutics is owned by 13.05% institutional investors, 26.22% insiders, and 60.72% retail investors. Cooperman leon g is the largest institutional shareholder, holding 3.69% of DMAC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.75% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	DiaMedica Therapeutics	13.05%	26.22%	60.72%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Cooperman leon g	1.40M	3.69%	$4.13M
Vanguard group	1.02M	2.68%	$3.00M
First manhattan co. llc.	839.08K	2.21%	$2.48M
Paragon associates & paragon associates ii joint venture	482.61K	1.27%	$1.42M
Bleichroeder lp	382.32K	1.01%	$1.13M
Geode capital management	236.89K	0.62%	$699.00K
Northern trust	120.39K	0.32%	$355.15K
Blackrock	105.30K	0.28%	$310.64K
Morgan stanley	86.20K	0.23%	$254.29K
State street	68.73K	0.18%	$202.75K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Paragon associates & paragon associates ii joint venture	482.61K	3.48%	$1.42M
Bleichroeder lp	382.32K	0.34%	$1.13M
Cooperman leon g	1.40M	0.17%	$4.13M
Catalyst financial partners	38.46K	0.02%	$113.45K
Magnolia capital advisors	10.00K	0.01%	$29.50K
First manhattan co. llc.	839.08K	0.01%	$2.48M
Naples money management	2.98K	0.01%	$8.79K
Stonebridge capital advisors	20.00K	0.01%	$59.00K
Legend financial advisors	1.00K	0.00%	$2.95K
Massmutual trust co fsb/adv	4.82K	0.00%	$14.23K

Top Buyers

Holder	Shares	% Assets	Change
Cooperman leon g	1.40M	0.17%	516.38K
Bleichroeder lp	382.32K	0.34%	160.00K
Lpl financial	17.50K	-	17.50K
Magnolia capital advisors	10.00K	0.01%	10.00K
Vanguard group	1.02M	0.00%	3.88K

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	43.37K	-	-165.96K
Aristides capital	-	-	-106.33K
Bank of new york mellon	-	-	-24.00K
Paragon associates & paragon associates ii joint venture	482.61K	3.48%	-17.39K
Jane street group	-	-	-15.09K

New Positions

Holder	Shares	% Assets	Change	Value
Lpl financial	17.50K	-	17.50K	$51.63K
Magnolia capital advisors	10.00K	0.01%	10.00K	$29.50K

Sold Out

Holder	Change
Toronto dominion bank	-24.00
Wells fargo & company/mn	-175.00
Federation des caisses desjardins du quebec	-230.00
Ubs group	-1.93K
Jane street group	-15.09K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	42	23.53%	5,580,411	10.22%	13	7.34%	22	83.33%	6	-33.33%
Jun 30, 2024	34	-	5,063,143	10.09%	13	6.69%	12	50.00%	9	12.50%
Mar 31, 2024	34	-15.00%	4,599,129	19.69%	14	13.77%	8	-55.56%	8	100.00%
Dec 31, 2023	40	2.56%	3,842,585	-9.61%	10	4.18%	18	-10.00%	4	-42.86%
Sep 30, 2023	39	18.18%	4,251,270	21.78%	15	8.94%	20	25.00%	7	40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	747.20K	1.75%	-
Vanguard Institutional Extnd Mkt Idx Tr	253.73K	0.59%	-
Fidelity Extended Market Index	152.40K	0.36%	25.24K
Jacob Discovery Fd Instl	122.73K	0.29%	-5.00K
iShares Micro-Cap ETF	55.12K	0.13%	-
Fidelity Total Market Index	48.90K	0.11%	26.92K
Fidelity Nasdaq Composite Index	42.74K	0.10%	-
BlackRock Extended Equity Market K	39.62K	0.09%	-17.00
Fidelity Series Total Market Index	35.16K	0.08%	8.89K
Vanguard Balanced Index Inv	24.55K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 28, 2024	Von Koch Thomas	-	Buy	$3.00M
Jun 28, 2024	STAHLBERG JAN	-	Buy	$3.00M
Nov 16, 2023	Wambeke David J.	Chief Business Officer	Buy	$49.20K
Jun 23, 2023	Von Koch Thomas	-	Buy	$5.00M
Jun 23, 2023	Giuffre Randall Michael	-	Buy	$254.15K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	1	-
2023 Q2	8	-
2023 Q1	-	-

DMAC Ownership FAQ

Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 13.05%, followed by 26.22% insiders and 60.73% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 47.04%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (1.4M shares, 3.69%), Vanguard group (1.02M shares, 2.68%), and First manhattan co. llc. (839.08K shares, 2.21%). Together, they hold 8.58% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

Yes, BlackRock owns 0.28% of DiaMedica Therapeutics, totaling 105.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 310.64K$. In the last quarter, BlackRock increased its holdings by 1.93K shares, a 1.87% change.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.48% of its assets in 482.61K DiaMedica Therapeutics shares, valued at 1.42M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.75% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools